Too Shy To Ask

Pune, India Founded: 2019 • Age: 7 yrs Listed
Provides online education on sexual health, mental health, and personal safety for teens and parents.
Request Access
Report Incorrect Data
Page last updated

About Too Shy To Ask

Too Shy To Ask is a publicly listed company based in Pune (India) founded in 2019. It provides online education on sexual health, mental health, and personal safety for teens and parents. It operates on a B2C and D2C model in Consumer and Healthcare sectors. The company has 4,503 employees. Its Indian entity Metropolis Healthcare Limited reported revenue of ₹1,671 Cr. Too Shy To Ask offers products and services including Educational Platform, FAQ Section, and Campaign Resources. Its focus areas include Health and Wellness, Mental Health Support, Youth Counseling and Digital Awareness.

Company details

Too Shy To Ask is an online platform that offers educational resources on topics like sexual health, mental health, relationships, and personal safety. It provides FAQs, campaigns, and interactive content to empower adolescents and their parents. Based in Mumbai, India, it focuses on creating safe spaces for discussions and includes testimonials from users. The platform promotes awareness through articles, videos, and community support, targeting young people in India to foster self-awareness and healthy living.

  • Headquarters Pune, India
  • Employees 4,503
  • Stage Public
  • Sectors
    Consumer
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website tooshytoask.org
  • Social X Facebook Instagram YouTube
  • Legal Name Metropolis Healthcare Limited
  • Date of Incorporation 10 Nov, 2000
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Consumer → Beauty & Personal Care Platforms
Healthcare → Pediatrics
Key Metrics
  • Market Cap
    ₹12,063 Cr

    METROPOLIS · NSE

  • Share Price
    ₹571.00

    -1.76% today

  • Revenue
    ₹1,646 Cr

    FY 2025-26 · +23.6% YoY

  • EBITDA
    ₹396 Cr

    Margin 24.1%

  • Net Profit
    ₹194 Cr

    FY 2025-26 · +42.3% YoY

  • P/E (TTM)
    55.8x

    P/B 7.7x

  • ROE
    13.4%

    ROCE 17.2%

  • Debt / Equity
    0.15

    Interest cover 11.0x

  • Employee Count
    4,503

Products & Services of Too Shy To Ask

Too Shy To Ask offers a comprehensive portfolio of products and services, including Educational Platform, FAQ Section, and Campaign Resources.

Educational Platform
Health Education

Online resource for sexual and mental health information for adolescents

FAQ Section
Information Service

Provides answers to queries on health and relationships

Campaign Resources
Community Outreach

Offers materials for awareness campaigns on youth issues

Apps and channels of Too Shy To Ask

Too Shy To Ask publishes 3 mobile apps with over 200K+ downloads; its YouTube channel Too Shy To Ask has 9 subscribers and 2 videos.

Too Shy To Ask
Google Play Education Everyone Free
Developer: Metropolis Foundation
View on Google Play
Too Shy To Ask
Google Play Education Everyone Free
Developer: Metropolis Foundation
View on Google Play
Too Shy To Ask
App Store Education 17+
Developer: Metropolis Foundation
View on App Store
Too Shy To Ask
YouTube 9 subscribers 2 videos Howto & Style
Open channel

Videos from Too Shy To Ask

The most watched videos on Too Shy To Ask's YouTube channel, Too Shy To Ask (9 subscribers). Click a video to play it here.

How To Prepare Your Daughter For Her First Period?
102 views
Dos and Don'ts of Parenting
98 views

More on Too Shy To Ask.

Board of directors of Metropolis Healthcare Limited (Too Shy To Ask)

Metropolis Healthcare Limited is the primary company behind Too Shy To Ask. The board of Metropolis Healthcare Limited currently have 10 directors; the longest-serving is Sushil Kanubhai Shah, appointed in 2005. 29 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sushil Kanubhai Shah
DIN 00179918
Director17 Aug 200521 yrs 2 moMetropolis Healthcare Limited
Ameera Sushil Shah
DIN 00208095
Whole-time director06 May 200818 yrs 5 moMetropolis Healthcare Limited
Vivek Gambhir
DIN 06527810
Director07 Sep 20188 yrs 1 moMetropolis Healthcare Limited
Sanjay Bhatnagar
DIN 00867848
Director07 Sep 20188 yrs 1 moMetropolis Healthcare Limited
Hemant Sachdev
DIN 01635195
Director27 May 20215 yrs 5 moMetropolis Healthcare Limited
Subramanian Ranganathan
DIN 00125493
Director21 Aug 20233 yrs 2 moMetropolis Healthcare Limited
Aparna Chetan Rajadhyaksha
DIN 10596037
Director22 May 20242 yrs 5 moMetropolis Healthcare Limited
Purvi Sheth
DIN 06449636
Director17 Mar 20251 yr 7 moMetropolis Healthcare Limited
Rehan Khan Abbas
DIN 02616924
Director13 May 20251 yr 5 moMetropolis Healthcare Limited
Chemmenkotil Surendran
DIN 10818890
Managing Director01 Jun 20251 yr 5 moMetropolis Healthcare Limited

IPO & Listings of Too Shy To Ask

Too Shy To Ask is a publicly listed company on the NSE with ticker symbol METROPOLIS in India, operating in the Healthcare sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: METROPOLIS
  • Listed entityMetropolis Healthcare Limited
  • Exchange sectorHealthcare

Financials of Too Shy To Ask

Exchange-reported figures of Metropolis Healthcare Limited, the listed company behind Too Shy To Ask (NSE: METROPOLIS).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹1,646 Cr
+23.6% YoY
EBITDA
₹396 Cr
+28.5% YoY
Profit After Tax
₹194 Cr
+42.3% YoY
Net Worth
₹1,513 Cr
+13.7% YoY
Total Assets
₹1,792 Cr
+14.5% YoY
Total Debt
₹232 Cr
+13.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,6461,3311,2081,1481,228998856
Revenue growth+23.6%+10.2%+5.2%-6.5%+23.1%+16.5%-
EBITDA396308288293348290212
EBITDA margin+24.1%+23.2%+23.8%+25.6%+28.3%+29.0%+24.8%
Profit before tax259191175188293244169
Net profit194136127143203183144
Net profit margin+11.8%+10.2%+10.5%+12.4%+16.5%+18.3%+16.8%
EPS (₹)9.1727.9924.9527.9041.8635.8225.15
Balance sheet
Total assets1,7921,5661,3121,2711,279830602
Net worth1,5131,3311,096988886707524
Total debt23220419726637911266.70
Cash & bank62.3249.0271.2293.19167420210
Net working capital87.5974.4394.88137215430236
Cash flow
Cash from operations351263264247253249215
Cash from investing(220)(199)(89.09)48.09(736)63.08(104)
Cash from financing(115)(86.63)(181)(292)163(32.69)(55.32)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue450425406429386345323350
Revenue growth (YoY)+16.6%+23.0%+25.8%+22.7%+23.2%---
Other income5.108.279.020.897.526.972.563.13
EBITDA11110885.7510889.7562.2972.0189.88
EBITDA margin+24.7%+25.4%+21.1%+25.2%+23.2%+18.0%+22.3%+25.7%
Depreciation32.4038.5931.8832.4130.8528.6227.7026.82
Interest6.187.935.735.685.204.604.534.79
Profit before tax77.7269.7757.1671.0261.2236.0442.3461.40
Tax20.8318.8015.0718.1315.986.8210.8614.70
Net profit56.8950.9742.0952.8945.2429.2231.4846.70
EPS (₹)2.732.467.9410.138.665.666.099.03
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,3651,2161,1031,0661,157816665
Revenue growth+12.3%+10.2%+3.5%-7.9%+41.8%+22.7%-
EBITDA334272263274324242152
EBITDA margin+24.5%+22.4%+23.9%+25.7%+28.0%+29.7%+22.8%
Profit before tax212162157179272246140
Net profit161116115139188198130
Net profit margin+11.8%+9.6%+10.4%+13.0%+16.2%+24.2%+19.5%
EPS (₹)7.6024.0922.6227.1338.9938.6522.13
Balance sheet
Total assets1,6021,4461,2421,2171,229801572
Net worth1,3891,2441,031936839709512
Total debt18217819526837784.9753.54
Cash & bank20.5525.5230.4642.94115335132
Net working capital9.7122.1661.97112189384185
Cash flow
Cash from operations318273269238244202156
Cash from investing(209)(194)(81.51)46.72(736)73.53(51.13)
Cash from financing(111)(84.50)(183)(288)172(26.33)(46.37)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue372352335356324312297322
Revenue growth (YoY)+15.0%+12.9%+12.7%+10.6%+13.1%---
Other income5.198.822.222.522.787.763.033.59
Total expenses279262263264247259232240
EBITDA93.6990.1372.1991.3577.0552.5265.1082.02
EBITDA margin+25.2%+25.6%+21.6%+25.7%+23.8%+16.9%+21.9%+25.5%
Depreciation27.8132.8027.7227.7927.8627.2726.8526.01
Interest4.776.564.373.974.294.434.494.73
Profit before tax66.3059.5942.3262.1147.6828.5836.7954.87
Tax15.7216.3510.2915.4812.104.739.3912.61

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 05 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue450425406429386345323350
Revenue growth (YoY)+16.6%+23.0%+25.8%+22.7%+23.2%---
Other income5.108.279.020.897.526.972.563.13
EBITDA11110885.7510889.7562.2972.0189.88
EBITDA margin+24.7%+25.4%+21.1%+25.2%+23.2%+18.0%+22.3%+25.7%
Depreciation32.4038.5931.8832.4130.8528.6227.7026.82
Interest6.187.935.735.685.204.604.534.79
Profit before tax77.7269.7757.1671.0261.2236.0442.3461.40
Tax20.8318.8015.0718.1315.986.8210.8614.70
Net profit56.8950.9742.0952.8945.2429.2231.4846.70
EPS (₹)2.732.467.9410.138.665.666.099.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,6461,3311,2081,1481,228998856
Revenue growth+23.6%+10.2%+5.2%-6.5%+23.1%+16.5%-
Other income25.5815.119.1215.2233.6212.058.57
Total expenses1,2501,023920855880708644
Employee cost377314276253233199190
EBITDA396308288293348290212
EBITDA margin+24.1%+23.2%+23.8%+25.6%+28.3%+29.0%+24.8%
Depreciation13410994.4789.2263.2245.9439.27
Interest28.9023.8927.8931.8525.0211.5612.65
Profit before tax259191175188293244169
Tax67.9945.3446.2344.1178.6660.9741.18
Net profit194136127143203183144
Net profit margin+11.8%+10.2%+10.5%+12.4%+16.5%+18.3%+16.8%
EPS (₹)9.1727.9924.9527.9041.8635.8225.15
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital41.4710.3610.2510.2410.2310.2210.13
Reserves & surplus1,4611,3131,078978876696513
Shareholders' funds (net worth)1,5131,3311,096988886707524
Minority interest11.393.673.122.481.971.461.66
Secured loans18.7314.190.0079.052590.000.00
Unsecured loans21319019718712011266.70
Total debt23220419726637911266.70
Total liabilities1,7921,5661,3121,2711,279830602
Assets
Gross block1,9011,6971,3821,2961,192438366
Net block1,6011,4471,1771,1211,059343296
Capital work in progress0.000.000.0019.515.780.002.99
Investments14271.0054.8314.8115.5110.0814.32
Inventories45.4947.8438.6944.5951.1140.5524.40
Sundry debtors170148126122135123128
Cash & bank balances62.3249.0271.2293.19167420210
Loans & advances49.8731.8926.5730.0025.8416.9121.37
Total current assets328277263290379600384
Total current liabilities240202168153164171149
Net working capital87.5974.4394.88137215430236
Total assets1,7921,5661,3121,2711,279830602
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash39.4862.6268.8365.9838710751.37
Net cash from operating activities351263264247253249215
Net cash from investing activities(220)(199)(89.09)48.09(736)63.08(104)
Net cash from financing activities(115)(86.63)(181)(292)163(32.69)(55.32)
Net change in cash15.31(23.14)(6.21)2.85(321)27955.80
Closing cash62.3249.0271.2293.19167420210
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+23.6%+10.2%+5.2%-6.5%+23.1%+16.5%-
EBITDA growth+28.5%+7.1%-1.9%-15.7%+20.1%+36.6%-
PBT growth+35.8%+9.3%-6.8%-36.1%+20.1%+44.8%-9.6%
Net income growth+42.3%+7.2%-11.0%-29.5%+10.9%+27.0%-
Revenue CAGR (3Y)+12.8%+2.7%+6.6%+10.3%+17.3%+15.5%+16.3%
EBITDA CAGR (3Y)+10.5%-4.0%-0.2%+11.4%+19.8%+17.5%+11.4%
Profitability & leverage
Net income margin+11.6%+10.9%+10.6%+12.5%+17.5%+18.4%+14.9%
Return on capital employed+17.2%+15.0%+15.7%+17.2%+30.2%+35.8%+39.5%
Return on net worth+13.4%+12.0%+12.3%+15.3%+27.0%+29.8%+30.6%
Debt / equity0.150.170.220.340.310.150.09
Long-term debt / equity0.090.100.130.210.200.110.05
Interest cover11.0111.9714.4215.608.794.747.32
Efficiency & per share
Fixed asset turnover0.910.860.900.921.512.482.69
Inventory turnover35.2730.7729.0024.0026.8030.7333.92
Debtors turnover10.349.719.738.929.507.946.46
EPS (₹)9.1727.9924.9527.9041.8635.8225.15
Dividend per share (₹)5.000.004.008.008.008.008.00
Book value per share (₹)72.46255.41212.47192.97173.18138.23103.40
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue372352335356324312297322
Revenue growth (YoY)+15.0%+12.9%+12.7%+10.6%+13.1%---
Other income5.198.822.222.522.787.763.033.59
Total expenses279262263264247259232240
EBITDA93.6990.1372.1991.3577.0552.5265.1082.02
EBITDA margin+25.2%+25.6%+21.6%+25.7%+23.8%+16.9%+21.9%+25.5%
Depreciation27.8132.8027.7227.7927.8627.2726.8526.01
Interest4.776.564.373.974.294.434.494.73
Profit before tax66.3059.5942.3262.1147.6828.5836.7954.87
Tax15.7216.3510.2915.4812.104.739.3912.61
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,3651,2161,1031,0661,157816665
Revenue growth+12.3%+10.2%+3.5%-7.9%+41.8%+22.7%-
Other income16.6717.5012.0021.2832.1548.6529.32
Total expenses1,032944840792833574514
Employee cost297272247228218157148
EBITDA334272263274324242152
EBITDA margin+24.5%+22.4%+23.9%+25.7%+28.0%+29.7%+22.8%
Depreciation11610590.7384.9660.2636.2030.85
Interest22.8022.9927.2531.2924.548.7510.01
Profit before tax212162157179272246140
Tax54.1137.0741.5240.0072.0148.4927.93
Net profit161116115139188198130
Net profit margin+11.8%+9.6%+10.4%+13.0%+16.2%+24.2%+19.5%
EPS (₹)7.6024.0922.6227.1338.9938.6522.13
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital41.4710.3610.2510.2410.2310.2210.13
Reserves & surplus1,3371,2261,013926829699502
Shareholders' funds (net worth)1,3891,2441,031936839709512
Secured loans0.000.000.0079.052590.000.00
Unsecured loans18217819518911984.9753.54
Total debt18217819526837784.9753.54
Total liabilities1,6021,4461,2421,2171,229801572
Assets
Gross block1,3921,3461,3131,2291,131321265
Net block1,1351,1291,1201,0661,005251216
Capital work in progress0.000.000.0019.515.780.002.99
Investments48432189.7349.7150.41131130
Inventories32.2131.5533.8941.2747.0133.4617.46
Sundry debtors119114130126140123124
Cash & bank balances20.5525.5230.4642.94115335132
Loans & advances39.8119.7824.9841.9636.5924.8128.21
Total current assets211191219252339516302
Total current liabilities202168157140150132117
Net working capital9.7122.1661.97112189384185
Total assets1,6021,4461,2421,2171,229801572
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash22.6828.5924.0927.4934867.438.80
Net cash from operating activities318273269238244202156
Net cash from investing activities(209)(194)(81.51)46.72(736)73.53(51.13)
Net cash from financing activities(111)(84.50)(183)(288)172(26.33)(46.37)
Net change in cash(2.62)(5.90)4.50(3.40)(320)25058.63
Closing cash20.5525.5230.4642.94115335132
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+12.3%+10.2%+3.5%-7.9%+41.8%+22.7%-
EBITDA growth+22.6%+3.4%-3.8%-15.5%+33.8%+60.0%-
PBT growth+30.7%+2.8%-12.0%-34.1%+10.4%+75.8%-6.2%
Net income growth+38.3%+0.9%-17.1%-26.1%-4.9%+52.3%-
Revenue CAGR (3Y)+8.6%+1.7%+10.6%+17.0%+25.8%+19.0%+18.0%
EBITDA CAGR (3Y)+6.8%-5.7%+2.8%+21.8%+30.0%+21.1%+7.8%
Profitability & leverage
Net income margin+11.5%+10.3%+10.5%+13.0%+17.3%+24.2%+16.8%
Return on capital employed+15.4%+13.8%+15.0%+17.2%+29.2%+37.1%+34.6%
Return on net worth+12.0%+11.0%+11.8%+15.7%+25.8%+32.4%+28.0%
Debt / equity0.140.160.240.360.300.110.08
Long-term debt / equity0.080.100.140.220.190.080.04
Interest cover10.4713.7415.7816.569.304.248.30
Efficiency & per share
Fixed asset turnover1.000.910.870.901.592.782.83
Inventory turnover42.8337.1629.3624.1528.7632.0535.86
Debtors turnover11.749.988.618.008.796.615.48
EPS (₹)7.6024.0922.6227.1338.9938.6522.13
Dividend per share (₹)5.000.004.008.008.008.008.00
Book value per share (₹)66.47238.71199.79182.78164.00138.69101.20

Web traffic of Too Shy To Ask

The website of Too Shy To Ask (tooshytoask.org) receives about 1.3K visits a month.

  • Monthly visits
    1.3K

    ▲ 52.5% vs previous month

Top companies in Beauty & Personal Care Platforms

3 companies that operate in the same segment as Too Shy To Ask (Beauty & Personal Care Platforms) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Anytime Astro
Online platform for astrology consultations, horoscopes, tarot readings, and spiritual advice services.
2021Jaipur, Rajasthan, IndiaUSD 1.11 M1
Abhyaasa
Mobile app for guided daily sadhana and meditation practices.
2015Bengaluru, Karnataka, India
Law Of Attraction App
Offers app-based tools for daily manifestation and goal setting exercises.
2020India
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Too Shy To Ask

Metropolis: Co Raises Lab Enhancement Outlook, Expecting 46% Boost in Lab Use by FY29 and Plan Price Increases in Q4 FY27 to Drive Higher Revenue and Margin Growth.
Exchange Update • 1 day ago
Metropolis: Co Guides For 120-170 Bps EBITDA Margin Expansion In Fy27, Backed By Planned Q4 B2C Price Hike And Lab Platform Completion
Exchange Update • 1 day ago
METROPOLIS: Q2 REVENUE 4.97B RUPEES VS 4.3B (YOY)
Exchange Update • 2 days ago
METROPOLIS: Q2 CONS NET PROFIT 753M RUPEES VS 527M (YOY)
Exchange Update • 2 days ago
METROPOLIS: Q2 EBITDA 1.34B RUPEES VS 1.1B (YOY); Q2 EBITDA MARGIN 26.96% VS 25.22% (YOY)
Exchange Update • 2 days ago
Metropolis Healthcare: Q2 FY27 Revenue Rises 15% Year-Over-Year Due To Strong Patient And Test Volume Growth, EBITDA Margins Increase.
Exchange Update • 1 month ago
Crisil Revises Metropolis Healthcare Outlook To 'Positive'; Reaffirms 'AA-' Rating – Outlook Business
Outlook Business • 1 month ago
Buy Metropolis Healthcare; target of Rs 675: ICICI Securities
Moneycontrol • 2 months ago
Buy Metropolis Healthcare; target of Rs 675: Emkay Global Financial
Moneycontrol • 2 months ago
METROPOLIS: Strong growth and margin expansion driven by specialty testing, technology, and network scale
Quartr • 2 months ago
Premium access

Complete news archive for Too Shy To Ask

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Too Shy To Ask

Too Shy To Ask was founded in 2019.

Too Shy To Ask is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

Too Shy To Ask has 4,503 employees.

The primary company behind Too Shy To Ask, Metropolis Healthcare Limited, reported revenue of ₹1,671 Cr for FY 2026, up 24% year on year.

Too Shy To Ask is an online platform that offers educational resources on topics like sexual health, mental health, relationships, and personal safety. It provides FAQs, campaigns, and interactive content to empower adolescents and their parents. Based in Mumbai, India, it focuses on creating safe spaces for discussions and includes testimonials from users. The platform promotes awareness through articles, videos, and community support, targeting young people in India to foster self-awareness and healthy living.

Too Shy To Ask offers Educational Platform, FAQ Section, and Campaign Resources.

Yes, Too Shy To Ask is publicly traded on NSE under the ticker symbol METROPOLIS.

Too Shy To Ask operates through Metropolis Healthcare Limited.

The legal entities of Too Shy To Ask currently have 12 directors, including Ameera Sushil Shah, Sushil Kanubhai Shah, Hemant Sachdev and others.

Yes. Too Shy To Ask publishes Too Shy To Ask and 2 more apps, with over 200,000 downloads.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available